1. Home
  2. JCE vs OPRX Comparison

JCE vs OPRX Comparison

Compare JCE & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCE
  • OPRX
  • Stock Information
  • Founded
  • JCE 2007
  • OPRX 2006
  • Country
  • JCE United States
  • OPRX United States
  • Employees
  • JCE N/A
  • OPRX N/A
  • Industry
  • JCE Trusts Except Educational Religious and Charitable
  • OPRX Business Services
  • Sector
  • JCE Finance
  • OPRX Consumer Discretionary
  • Exchange
  • JCE Nasdaq
  • OPRX Nasdaq
  • Market Cap
  • JCE 266.3M
  • OPRX 380.6M
  • IPO Year
  • JCE N/A
  • OPRX N/A
  • Fundamental
  • Price
  • JCE $15.59
  • OPRX $18.75
  • Analyst Decision
  • JCE
  • OPRX Buy
  • Analyst Count
  • JCE 0
  • OPRX 8
  • Target Price
  • JCE N/A
  • OPRX $11.81
  • AVG Volume (30 Days)
  • JCE 49.7K
  • OPRX 379.5K
  • Earning Date
  • JCE 01-01-0001
  • OPRX 11-12-2025
  • Dividend Yield
  • JCE 9.26%
  • OPRX N/A
  • EPS Growth
  • JCE N/A
  • OPRX N/A
  • EPS
  • JCE N/A
  • OPRX N/A
  • Revenue
  • JCE N/A
  • OPRX $104,748,000.00
  • Revenue This Year
  • JCE N/A
  • OPRX $17.92
  • Revenue Next Year
  • JCE N/A
  • OPRX $10.91
  • P/E Ratio
  • JCE N/A
  • OPRX N/A
  • Revenue Growth
  • JCE N/A
  • OPRX 25.89
  • 52 Week Low
  • JCE $11.64
  • OPRX $3.78
  • 52 Week High
  • JCE $14.28
  • OPRX $20.70
  • Technical
  • Relative Strength Index (RSI)
  • JCE 47.81
  • OPRX 52.93
  • Support Level
  • JCE $15.45
  • OPRX $17.24
  • Resistance Level
  • JCE $15.94
  • OPRX $20.70
  • Average True Range (ATR)
  • JCE 0.26
  • OPRX 1.16
  • MACD
  • JCE -0.01
  • OPRX -0.12
  • Stochastic Oscillator
  • JCE 50.00
  • OPRX 43.64

About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest

Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to provide an attractive level of total return, through long-term capital appreciation and through income and gains. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities.

About OPRX OptimizeRx Corporation

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

Share on Social Networks: